CAR T-Cell Therapy Market

Market Study on CAR T-Cell Therapy: Requirement for Treatment of Relapsed Large B-Cell Lymphoma High

Car T Cell Therapy Market Segmented By Yescarta, Kymriah, JCAR017, bb2121 Product with Relapsed Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Multiple Myeloma Indication

  • November-2021
  • PMRREP28264
  • 150 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage/Taxonomy

    2.2. Market Definition/Scope

3. Key Success Factors

    3.1. Iceberg Analysis

    3.2. Revenue Opportunity Analysis

    3.3. Parent Market Analysis

    3.4. Pipeline Assessment

    3.5. Potential Population Eligible for CAR T-cell Therapy, By Region

    3.6. List of Authorized Treatment Centers in the U.S. & U.K.

    3.7. Key Inclusion & Exclusion

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Outlook

        4.1.2. Global Healthcare Expenditure Outlook

    4.2. Forecast Factors – Relevance & Impact

        4.2.1. Increasing Availability of CAR T-cell Therapy

        4.2.2. Increasing Adoption of CAR T-cell Therapy

        4.2.3. Superior Product Efficacy

        4.2.4. Improving Reimbursement Scenario

        4.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

5. COVID-19 Crisis Impact Analysis

        5.1.1. Current COVID-19 Probable Future Impact

        5.1.2. Current GDP Projection and Probable Impact

        5.1.3. Current Economic Projection as compared to 2008 Economic analysis

        5.1.4. COVID19 and Impact Analysis

            5.1.4.1. Revenue By Product

            5.1.4.2. Revenue By Indication

            5.1.4.3. Revenue By End User

            5.1.4.4. Revenue By Country

6. Global Car T cell Therapy Market Value (Size US$Mn) Analysis 2016-2020 and Forecast 2021-2031,

    6.1. Historical Market Value (US$Mn) Analysis, 2016-2020

    6.2. Current and Future Market Value (US$Mn) Projections, 2021-2031

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Car T cell Therapy Market Value (Size US$Mn) Analysis 2016-2020 and Forecast 2021-2031,By Product

    7.1. Introduction/Key Findings

    7.2. Historical Market Value (US$Mn) Analysis, By Product, 2016-2020

    7.3. Current and Future Market Value (US$Mn) Projections, By Product, 2021-2031

        7.3.1. Yescarta (axicabtagene ciloleucel)

        7.3.2. Kymriah (tisagenlecleucel)

        7.3.3. JCAR017 (lisocabtagene maraleucel)

        7.3.4. bb2121

    7.4. Market Attractiveness By Product

8. Global Car T cell Therapy Market Value (Size US$Mn) Analysis 2016-2020 and Forecast 2021-2031,By Indication

    8.1. Introduction/Key Findings

    8.2. Historical Market Value (US$Mn) Analysis, By Indication, 2016-2020

    8.3. Current and Future Market Value (US$Mn) Projections, By Indication, 2021-2031

        8.3.1. Relapsed Large B-cell Lymphoma

        8.3.2. Acute Lymphoblastic Leukemia (ALL)

        8.3.3. Multiple Myeloma

    8.4. Market Attractiveness By Indication

9. Global Car T cell Therapy Market Value (Size US$Mn) Analysis 2016-2020 and Forecast 2021-2031,By End User

    9.1. Introduction/Key Findings

    9.2. Historical Market Value (US$Mn) Analysis, By End User, 2016-2020

    9.3. Current and Future Market Value (US$Mn) Projections, By End User, 2021-2031

            9.3.1.1. Hospitals

            9.3.1.2. Cancer Treatment Centers

    9.4. Market Attractiveness By End User

10. Global Car T cell Therapy Market Value (Size US$Mn) Analysis 2016-2020 and Forecast 2021-2031,By Region

    10.1. Introduction/Key Findings

    10.2. Historical Market Value (US$Mn) Analysis, By Region, 2016-2020

    10.3. Current Market Size (US$Mn) Analysis and Forecast By Region, 2021-2031

        10.3.1. North America

        10.3.2. Latin America

        10.3.3. Europe

        10.3.4. South Asia

        10.3.5. East Asia

        10.3.6. Oceania

        10.3.7. Middle East & Africa

    10.4. Market Attractiveness By Region

11. North America Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    11.1. Introduction

    11.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    11.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        11.3.1. By Country

            11.3.1.1. U.S.

            11.3.1.2. Canada

        11.3.2. By Product

        11.3.3. By Indication

        11.3.4. By End User

    11.4 Market Attractiveness Analysis

12. Latin America Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    12.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        12.3.1. By Country

            12.3.1.1. Brazil

            12.3.1.2. Mexico

            12.3.1.3. Argentina

            12.3.1.4. Rest of Latin America

        12.3.2. By Product

        12.3.3. By Indication

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

13. Europe Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    13.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        13.3.1. By Country

            13.3.1.1. U.K.

            13.3.1.2. Germany

            13.3.1.3. France

            13.3.1.4. Italy

            13.3.1.5. Spain

            13.3.1.6. Russia

            13.3.1.7. BENELUX

            13.3.1.8. Rest of Europe

        13.3.2. By Product

        13.3.3. By Indication

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

14. South Asia Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    14.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        14.3.1. By Country

            14.3.1.1. India

            14.3.1.2. Thailand

            14.3.1.3. Indonesia

            14.3.1.4. Malaysia

            14.3.1.5. Rest of South Asia

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

15. East Asia Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    15.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        15.3.1. By Country

            15.3.1.1. China

            15.3.1.2. Japan

            15.3.1.3. South Korea

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

16. Oceania Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    16.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        16.3.1. By Country

            16.3.1.1. Australia

            16.3.1.2. New Zealand

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

17. Middle East & Africa Car T cell Therapy Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Historical Market Size (US$Mn) Trend Analysis, By Market Taxonomy, 2016-2020

    17.3. Current Market Size (US$Mn) Forecast By Market Taxonomy,2021-2031

        17.3.1. By Country

            17.3.1.1. Turkey

            17.3.1.2. South Africa

            17.3.1.3. GCC Countries

            17.3.1.4. Rest of Middle East & Africa

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

18. Key and Emerging Countries Car T cell Therapy Market Analysis 2021 & 2031

    18.1. U.S. Car T cell Therapy Market Analysis

        18.1.1. By Product

        18.1.2. By Indication

        18.1.3. By End User

    18.2. Canada Car T cell Therapy Market Analysis

        18.2.1. By Product

        18.2.2. By Indication

        18.2.3. By End User

    18.3. Brazil Car T cell Therapy Market Analysis

        18.3.1. By Product

        18.3.2. By Indication

        18.3.3. By End User

    18.4. Mexico Car T cell Therapy Market Analysis

        18.4.1. By Product

        18.4.2. By Indication

        18.4.3. By End User

    18.5. Argentina Car T cell Therapy Market Analysis

        18.5.1. By Product

        18.5.2. By Indication

        18.5.3. By End User

    18.6. U.K. Car T cell Therapy Market Analysis

        18.6.1. By Product

        18.6.2. By Indication

        18.6.3. By End User

    18.7. Germany Car T cell Therapy Market Analysis

        18.7.1. By Product

        18.7.2. By Indication

        18.7.3. By End User

    18.8. France Car T cell Therapy Market Analysis

        18.8.1. By Product

        18.8.2. By Indication

        18.8.3. By End User

    18.9. Italy Car T cell Therapy Market Analysis

        18.9.1. By Product

        18.9.2. By Indication

        18.9.3. By End User

    18.10. Spain Car T cell Therapy Market Analysis

        18.10.1. By Product

        18.10.2. By Indication

        18.10.3. By End User

    18.11. Russia Car T cell Therapy Market Analysis

        18.11.1. By Product

        18.11.2. By Indication

        18.11.3. By End User

    18.12. BENELUX Car T cell Therapy Market Analysis

        18.12.1. By Product

        18.12.2. By Indication

        18.12.3. By End User

    18.13. India Car T cell Therapy Market Analysis

        18.13.1. By Product

        18.13.2. By Indication

        18.13.3. By End User

    18.14. ASEAN Car T cell Therapy Market Analysis

        18.14.1. By Product

        18.14.2. By Indication

        18.14.3. By End User

    18.15. China Car T cell Therapy Market Analysis

        18.15.1. By Product

        18.15.2. By Indication

        18.15.3. By End User

    18.16. Japan Car T cell Therapy Market Analysis

        18.16.1. By Product

        18.16.2. By Indication

        18.16.3. By End User

    18.17. South Korea Car T cell Therapy Market Analysis

        18.17.1. By Product

        18.17.2. By Indication

        18.17.3. By End User

    18.18. Australia Car T cell Therapy Market Analysis

        18.18.1. By Product

        18.18.2. By Indication

        18.18.3. By End User

    18.19. New Zealand Car T cell Therapy Market Analysis

        18.19.1. By Product

        18.19.2. By Indication

        18.19.3. By End User

    18.20. GCC Countries Car T cell Therapy Market Analysis

        18.20.1. By Product

        18.20.2. By Indication

        18.20.3. By End User

    18.21. Turkey Car T cell Therapy Market Analysis

        18.21.1. By Product

        18.21.2. By Indication

        18.21.3. By End User

    18.22. South Africa Car T cell Therapy Market Analysis

        18.22.1. By Product

        18.22.2. By Indication

        18.22.3. By End Users

19. Market Structure Analysis

    19.1. Market Analysis By Tier of Companies

    19.2. Market Share Analysis By Key Players

            19.2.1.1. Regional footprint of Players

            19.2.1.2. Service Footprint by players

            19.2.1.3. Channel Foot Print by Players

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Deep Dive

        20.2.1. Novartis AG

            20.2.1.1. Overview

            20.2.1.2. Product Portfolio

            20.2.1.3. Profitability by Market Segments (Product /End User/Region)

            20.2.1.4. Sales Footprint

            20.2.1.5. Strategy Overview

                20.2.1.5.1. Marketing Strategy

                20.2.1.5.2. Service Strategy

                20.2.1.5.3. End User Strategy

        20.2.2. Gilead Sciences Inc.

            20.2.2.1. Overview

            20.2.2.2. Product Portfolio

            20.2.2.3. Profitability by Market Segments (Product /End User/Region)

            20.2.2.4. Sales Footprint

            20.2.2.5. Strategy Overview

                20.2.2.5.1. Marketing Strategy

                20.2.2.5.2. Service Strategy

                20.2.2.5.3. End User Strategy

        20.2.3. Celgene Corporation

            20.2.3.1. Overview

            20.2.3.2. Product Portfolio

            20.2.3.3. Profitability by Market Segments (Product /End User/Region)

            20.2.3.4. Sales Footprint

            20.2.3.5. Strategy Overview

                20.2.3.5.1. Marketing Strategy

                20.2.3.5.2. Service Strategy

                20.2.3.5.3. End User Strategy

        20.2.4. bluebird bio, Inc.

            20.2.4.1. Overview

            20.2.4.2. Product Portfolio

            20.2.4.3. Profitability by Market Segments (Product /End User/Region)

            20.2.4.4. Sales Footprint

            20.2.4.5. Strategy Overview

                20.2.4.5.1. Marketing Strategy

                20.2.4.5.2. Service Strategy

                20.2.4.5.3. End User Strategy

21. Assumptions & Acronyms

22. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: Global CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 02: Global CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 03: Global CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 04: Global CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 05: Global CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 06: North America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 07: North America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 08: North America CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 09: North America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 10: North America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 11: Latin America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 12: Latin America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 13: Latin America CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 14: Latin America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 15: Latin America CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 16: Europe CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 17: Europe CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 18: Europe CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 19: Europe CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 20: Europe CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 21: South Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 22: South Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 23: South Asia CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 24: South Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 25: South Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 26: East Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 27: East Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 28: East Asia CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 29: East Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 30: East Asia CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 31: Oceania CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 32: Oceania CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 33: Oceania CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 34: Oceania CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 35: Oceania CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Table 36: MEA CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 37: MEA CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 38: MEA CAR T Cell Therapy Market Volume (in Units) Analysis and Opportunity Assessment 2016–2031, By Product

Table 39: MEA CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Indication

Table 40: MEA CAR T Cell Therapy Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By End User

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 1: Global CAR T Cell Therapy Market Value Share, By Product (2021)

Figure 2: Global CAR T Cell Therapy Market Value Share, By Indication (2021)

Figure 3: Global CAR T Cell Therapy Market Value Share By End User (2021)

Figure 4: Global CAR T Cell Therapy Market Value Share By Region (2021)

Figure 05: Global CAR T Cell Therapy Market Volume (in Units) Analysis, 2016-2020

Figure 06: Global CAR T Cell Therapy Market Volume Forecast (in Units), 2021-2031

Figure 07: CAR T Cell Therapy Market Average Pricing Analysis, by Product, 2020

Figure 08: CAR T Cell Therapy Market Average Pricing Analysis, By Product, 2031

Figure 09: Global CAR T Cell Therapy Market Value Analysis (US$ Mn), 2016-2020

Figure 10: Global CAR T Cell Therapy Market Value Analysis (US$ Mn), 2021–2031

Figure 11: Global CAR T Cell Therapy Market Absolute $ Opportunity, 2021-2031

Figure 12: Global CAR T Cell Therapy Market Share Analysis (%) By Product, 2021 & 2031

Figure 13: Global CAR T Cell Therapy Market Y-o-Y Growth (%) By Product, 2021-2031

Figure 14: Global CAR T Cell Therapy Market Attractiveness Analysis, By Product

Figure 15: Global CAR T Cell Therapy Market Share Analysis (%) By Indication, 2021 & 2031

Figure 16: Global CAR T Cell Therapy Market Y-o-Y Growth (%) By Indication, 2021-2031

Figure 17: Global CAR T Cell Therapy Market Attractiveness Analysis, By Indication

Figure 18: Global CAR T Cell Therapy Market Share Analysis (%) By End User, 2021 & 2031

Figure 19: Global CAR T Cell Therapy Market Y-o-Y Growth (%) By End User, 2021-2031

Figure 20: Global CAR T Cell Therapy Market Attractiveness Analysis, By End User

Figure 21: Global CAR T Cell Therapy Market Share Analysis (%) By Region, 2021 & 2031

Figure 22: Global CAR T Cell Therapy Market Y-o-Y Growth (%) By Region, 2021-2031

Figure 23: Global CAR T Cell Therapy Market Attractiveness Analysis, By Region

Figure 24: North America CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 25: North America CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 26: North America CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 27: North America CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 28: North America CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 29: North America CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 30: North America CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 31: North America CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 32: North America CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 33: North America CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 34: Latin America CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 35: Latin America CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 36: Latin America CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 37: Latin America CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 38: Latin America CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 39: Latin America CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 40: Latin America CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 41: Latin America CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 42: Latin America CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 43: Latin America CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 44: Europe CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 45: Europe CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 46: Europe CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 47: Europe CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 48: Europe CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 49: Europe CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 50: Europe CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 51: Europe CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 52: Europe CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 53: Europe CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 54: South Asia CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 55: South Asia CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 56: South Asia CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 57: South Asia CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 58: South Asia CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 59: South Asia CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 60: South Asia CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 61: South Asia CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 62: South Asia CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 63: South Asia CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 64: East Asia CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 65: East Asia CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 66: East Asia CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 67: East Asia CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 68: East Asia CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 69: East Asia CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 70: East Asia CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 71: East Asia CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 72: East Asia CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 73: East Asia CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 74: Oceania CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 75: Oceania CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 76: Oceania CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 77: Oceania CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 78: Oceania CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 79: Oceania CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 80: Oceania CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 81: Oceania CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 82: Oceania CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 83: Oceania CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 84: MEA CAR T Cell Therapy Market Value Share, By Product, 2021 (E)

Figure 85: MEA CAR T Cell Therapy Market Value Share, By Indication, 2021 (E)

Figure 86: MEA CAR T Cell Therapy Market Value Share, By End User, 2021 (E)

Figure 87: MEA CAR T Cell Therapy Market Value Share, By Country, 2021 (E)

Figure 88: MEA CAR T Cell Therapy Market Size (US$ Mn), 2016-2020

Figure 89: MEA CAR T Cell Therapy Market Size (US$) & Y-o-Y Growth (%), 2021-2031

Figure 90: MEA CAR T Cell Therapy Market Attractiveness Analysis, By Product, 2021E

Figure 91: MEA CAR T Cell Therapy Market Attractiveness Analysis, By Indication, 2021E

Figure 92: MEA CAR T Cell Therapy Market Attractiveness Analysis, By End User, 2021E

Figure 93: MEA CAR T Cell Therapy Market Attractiveness Analysis, By Country, 2021E

Figure 94: Global Vs. U.S. Growth Comparison

Figure 95: U.S. CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 96: U.S. CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 97: U.S. CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 98: Global Vs. Canada Growth Comparison

Figure 99: Canada CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 100: Canada CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 101: Canada CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 102: Global Vs. Brazil Growth Comparison

Figure 103: Brazil CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 104: Brazil CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 105: Brazil CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 106: Global Vs. Mexico Growth Comparison

Figure 107: Mexico CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 108: Mexico CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 109: Mexico CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 110: Global Vs. Germany Growth Comparison

Figure 111: Germany CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 112: Germany CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 113: Germany CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 114: Global Vs. Italy Growth Comparison

Figure 115: Italy CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 116: Italy CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 117: Italy CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 118: Global Vs. France Growth Comparison

Figure 119:  France CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 120:  France CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 121:  France CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 122: Global Vs. U.K. Growth Comparison

Figure 123: U.K. CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 124: U.K. CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 125: U.K. CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 126: Global Vs. Spain Growth Comparison

Figure 127: Spain CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 128: Spain CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 129: Spain CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 130: Global Vs. BENELUX Growth Comparison

Figure 131: BENELUX CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 132: BENELUX CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 133: BENELUX CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 134: Global Vs. Russia Growth Comparison

Figure 135:  Russia CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 136:  Russia CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 137:  Russia CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 138: Global Vs. China Growth Comparison

Figure 139: China CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 140: China CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 141: China CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 142: Global Vs. Japan Growth Comparison

Figure 143: Japan CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 144: Japan CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 145: Japan CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 146: Global Vs. South Korea Growth Comparison

Figure 147: South Korea CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 148: South Korea CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 149: South Korea CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 150: Global Vs. India Growth Comparison

Figure 151: India CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 152: India CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 153: India CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 154: Global Vs. Malaysia Growth Comparison

Figure 155: Malaysia CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 156: Malaysia CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 157: Malaysia CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 158: Global Vs. Thailand Growth Comparison

Figure 159: Thailand CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 160: Thailand CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 161: Thailand CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 162: Global Vs. Indonesia Growth Comparison

Figure 163: Indonesia CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 164: Indonesia CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 165: Indonesia CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 166: Global Vs. Australia Growth Comparison

Figure 167: Australia CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 168: Australia CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 170: Global Vs. New Zealand Growth Comparison

Figure 171: New Zealand CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 172: New Zealand CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 173: New Zealand CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 174: Global Vs. GCC Countries Growth Comparison

Figure 175: GCC Countries CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 176: GCC Countries CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 177: GCC Countries CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 178: Global Vs. Turkey Growth Comparison

Figure 179: Turkey CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 180: Turkey CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 181: Turkey CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Figure 182: Global Vs. South Africa Growth Comparison

Figure 183: South Africa CAR T Cell Therapy Market Share Analysis (%), by Product, 2021 & 2031

Figure 184: South Africa CAR T Cell Therapy Market Share Analysis (%), by Indication, 2021 & 2031

Figure 185: South Africa CAR T Cell Therapy Market Share Analysis (%), by End User, 2021 & 2031

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

CAR T-Cell Therapy Market- Scope of Report

The latest publication by Persistence Market Research on the CAR T-cell therapy market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for CAR T-cell therapy market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the CAR T-cell therapy market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the CAR T-cell therapy market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the CAR T-cell therapy market offers information divided into four important segments – product, indication, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

  • Yescarta (axicabtagene ciloleucel)
  • Kymriah (tisagenlecleucel)
  • JCAR017 (lisocabtagene maraleucel)
  • bb2121

Indication

  • Relapsed Large B-cell Lymphoma
  • Acute Lymphoblastic Leukemia (ALL)
  • Multiple Myeloma

End User

  • Hospitals
  • Cancer Treatment Centers

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for CAR T-cell therapy over the coming years?
  • How will changing trends impact the market?
  • How has the COVID-19 crisis impacted market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will impact the market?
  • How can companies in the market avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the CAR T-cell therapy market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the CAR T-cell therapy market more accurate and reliable.

Recommendations

White Spirit Market

White Spirits Market are of four types - Type 1, Type 2, Type 3, and Type 0, which are categorized on their aromatic content basis. White spirits are consumed in a wide range of applications such as paint thinners, cleaning solvents, degreasing solvents, fuels, and disinfectants, among others..

Dearomatic Solvents Market

The global de-aromatic solvents market is estimated to expand at a CAGR of more than 6% over the forecast period of 2021-2031..

Isoparaffin Solvents Market

The incremental $ opportunity created by the market during the forecast period is pegged at nearly US$ 51.9 Mn. The isoparaffin solvents market is expected to expand at a CAGR of 3.7% during the forecast period..

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Our Clients

Our Clients